Rein Therapeutics Inc.
RNTX
$1.27
$0.1412.39%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -59.15M | -61.27M | -62.88M | -29.24M | -25.22M |
| Total Depreciation and Amortization | 1.00K | 4.00K | 63.00K | 115.00K | 127.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 38.16M | 38.23M | 38.12M | 1.43M | 1.11M |
| Change in Net Operating Assets | -235.00K | -159.00K | 2.41M | -176.00K | -1.71M |
| Cash from Operations | -21.22M | -23.20M | -22.29M | -27.87M | -25.69M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 42.00K |
| Cash Acquisitions | -- | -- | -- | -96.00K | -96.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 500.00K |
| Cash from Investing | -- | -- | -- | -96.00K | 446.00K |
| Total Debt Issued | -- | -- | -- | 15.79M | 15.79M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.99M | 11.78M | 11.04M | 11.04M | 11.04M |
| Repurchase of Common Stock | -7.48M | -7.48M | -7.48M | -7.48M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 10.50M | 14.26M | 14.26M | 14.26M | 7.23M |
| Cash from Financing | 5.01M | 18.56M | 17.82M | 33.61M | 34.06M |
| Foreign Exchange rate Adjustments | -1.00K | 0.00 | 0.00 | -62.00K | -62.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.22M | -4.64M | -4.47M | 5.58M | 8.75M |